Glucagon-like peptide-1(7–36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns
The DOI matches its Crossref record.
Abstract
The acute effects of different macronutrients on the secretion of glucagon-like peptide-1(7–36)amide (GLP-1(7–36)amide) and glucose-dependent insulinotropic polypeptide (GIP) were compared in healthy human subjects. Circulating levels of the two hormones were measured over a 24-h period during which subjects consumed a mixed diet. In the first study, eight subjects consumed three equicaloric (375 kcal) test meals of carbohydrate, fat and protein. Small increases in plasma GLP-1(7–36) amide were found after all meals. Levels reached a maximum 30 min after the carbohydrate and 150 min after the fat load. Ingestion of both carbohydrate and fat induced substantial rises in GIP secretion, but the protein meal had no effect. In a second study, eight subjects consumed 75 g glucose or the equivalent portion of complex carbohydrate as boiled brown rice or barley. Plasma GIP, insulin and glucose levels increased after all three meals, the largest increase being observed following glucose and the smallest following the barley meal. Plasma GLP-1(7–36)amide levels rose only following the glucose meal. In the 24-h study, plasma GLP-1(7–36)amide and GIP concentrations were increased following every meal and remained elevated throughout the day, only falling to fasting levels at night. The increases in circulating GLP-1(7–36)amide and GIP levels following carbohydrate or a mixed meal are consistent with their role as incretins. The more sustained rises observed in the daytime during the 24-h study are consistent with an anabolic role in lipid metabolism. Journal of Endocrinology (1993) 138, 159–166
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The gut-derived hormones GLP-1 and GIP, which are secreted from enteroendocrine L-cells66 and K-cells,67 respectively, upon glucose,66, 68 fructose,69 amino acid70 and free fatty acid (FFA)71, 72 ingestion, also potentiate insulin release through the so-called incretin effect.”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [68]
Citations
Cites
Still being checked.
Cited by
Items 301–400 of 696
Holst, J. J., & McGill, M. A. (2011) · Clinical Drug Investigation · doi:10.2165/11595370-000000000-00000 · Cited by 44
Distribution and Stimulus Secretion Coupling of Enteroendocrine Cells along the Intestinal Tract
Adriaenssens, A. E., Reimann, F., & Gribble, F. M. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170047 · Cited by 41
Adachi, T., Tanaka, T., Takemoto, K., Koshimizu, T., Hirasawa, A., & Tsujimoto, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.162 · Cited by 43
GIP and GLP-1(7–36)amide secretion in response to intraduodenal infusions of nutrients in pigs
Knapper, J. M. E., Heath, A., Fletcher, J. M., Morgan, L., & Marks, V. (1995) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/0742-8413(95)00046-1 · Cited by 40
Self-citationGuo, X.-H. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1103214 · Cited by 33
Pendharkar, S. A., Singh, R. G., Chand, S. K., Cervantes, A., & Petrov, M. S. (2017) · Inflammation Research · doi:10.1007/s00011-017-1125-4 · Cited by 43
Connor, E. E., Evock-Clover, C. M., Walker, M. P., Elsasser, T. H., & Kahl, S. (2015) · Journal of Animal Science · doi:10.2527/jas.2014-8577 · Cited by 43
Boer, G. A., Keenan, S. N., Miotto, P. M., Holst, J. J., & Watt, M. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00646.2020 · Cited by 38
Matching Meals to Body Clocks—Impact on Weight and Glucose Metabolism
Hutchison, A. T., Wittert, G., & Heilbronn, L. K. (2017) · Nutrients · doi:10.3390/nu9030222 · Cited by 41
Glucagon-like peptide-1 regulation by food proteins and protein hydrolysates
Miguéns‐Gómez, A., Casanova-Martí, À., Blay, M., Terra, X., Beltrán‐Debón, R., Rodríguez‐Gallego, E., Ardèvol, A., & Pinent, M. (2021) · Nutrition Research Reviews · doi:10.1017/s0954422421000019 · Cited by 41
McKay, N. J., & Daniels, D. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12086 · Cited by 37
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes
Bak, A. M., Egefjord, L., Gejl, M., Steffensen, C., Stecher, C. W., Smidt, K., Brock, B., & Rungby, J. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.600691 · Cited by 36
Rolin, B., Deacon, C. F., Carr, R. D., & Åhrén, B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.013 · Cited by 37
Plasticity of gastro-intestinal vagal afferent endings
Kentish, S. J., & Page, A. J. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.03.012 · Cited by 37
Mace, O. J., & Marshall, F. H. (2012) · Journal of Animal Science · doi:10.2527/jas.2012-5906 · Cited by 43
Chapman, C. M. L., Morgan, L., & Murphy, M. C. (2000) · Journal of Nutrition · doi:10.1093/jn/130.2.146 · Cited by 37
Self-citationLiu, H., Xiao, H., Lin, S., Zhou, H., Cheng, Y., Xie, B., & Xu, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1372399 · Cited by 41
O’Connor, K. L., Scisco, J. L., Smith, T. J., Young, A., Montain, S. J., Price, L. L., Lieberman, H. R., & Karl, J. P. (2016) · Journal of Nutrition · doi:10.3945/jn.115.217976 · Cited by 37
Giezenaar, C., van der Burgh, Y., Lange, K. M., Hatzinikolas, S., Hausken, T., Jones, K. L., Horowitz, M., Chapman, I., & Soenen, S. (2018) · Nutrients · doi:10.3390/nu10020113 · Cited by 38
Hytting-Andreasen, R., Balk-Møller, E., Hartmann, B., Pedersen, J., Windeløv, J. A., Holst, J. J., & Kissow, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198046 · Cited by 36
Repositioning the Alpha Cell in Postprandial Metabolism
EL, K. M., Capozzi, M. E., & Campbell, J. E. (2020) · Endocrinology · doi:10.1210/endocr/bqaa169 · Cited by 37
Shimotoyodome, A., Fukuoka, D., Suzuki, J. S., Fujii, Y., Mizuno, T., Meguro, S., Tokimitsu, I., & Hase, T. (2009) · Endocrinology · doi:10.1210/en.2008-1162 · Cited by 37
Lu, W. J., Yang, Q., Sun, W. Y., Woods, S. C., D’Alessio, D. A., & Tso, P. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00400.2007 · Cited by 39
On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus.
Vilsbøll, T. (2004) · PubMed · Cited by 44
Hargrove, D. M., Nardone, N. A., Persson, L. M., Parker, J. C., & Stevenson, R. W. (1995) · Metabolism · doi:10.1016/0026-0495(95)90021-7 · Cited by 36
Synthesis and secretion of glucagon-like peptide-1 by fetal rat intestinal cells in culture
Huang, T., & Brubaker, P. L. (1995) · Endocrine · doi:10.1007/bf02738824 · Cited by 36
GIP’s involvement in the pathophysiology of type 2 diabetes
Christensen, M. B., Gasbjerg, L. S., Heimbürger, S. M., Stensen, S., Vilsbøll, T., & Knop, F. K. (2020) · Peptides · doi:10.1016/j.peptides.2019.170178 · Cited by 35
Jackson, K. G., KNAPPER-FRANCIS, J. M. E., Morgan, L., WEBB, D. H., Zampelas, A., & Williams, C. M. (2003) · Clinical Science · doi:10.1042/cs20030134 · Cited by 41
Self-citationYoshino, Y., Ishisaka, M., Tsujii, S., Shimazawa, M., & Hara, H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.098 · Cited by 36
Fransson, L., dos Santos, C., Wolbert, P., Sjöholm, Å., Rafacho, A., & Ortsäter, H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-3 · Cited by 34
Giezenaar, C., Lange, K. M., Hausken, T., Jones, K. L., Horowitz, M., Chapman, I. M., & Soenen, S. (2018) · Nutrients · doi:10.3390/nu10101451 · Cited by 42
Shirazi‐Beechey, S. P., Moran, A. W., Bravo, D., & Al-Rammahi, M. A. (2011) · Journal of Animal Science · doi:10.2527/jas.2010-3695 · Cited by 41
Protein digestion and energy homeostasis: How generated peptides may impact intestinal hormones?
Caron, J., Domenger, D., Belguesmia, Y., Kouach, M., Lésage, J., Goossens, J., Dhulster, P., Ravallec, R., & Cudennec, B. (2015) · Food Research International · doi:10.1016/j.foodres.2015.12.018 · Cited by 36
Inhibition of Human Gastric Lipase Secretion by Glucagon-like Peptide-1
Wøjdemann, M., Wettergren, A., Sternby, B., Holst, J. J., Larsen, S., Rehfeld, J. F., & Olsen, O. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018874300026 · Cited by 38
Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat
Giralt, M., & Vergara, P. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00010-x · Cited by 42
Tang, S., & Sambanis, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00399-1 · Cited by 37
Glucagon-like Peptide-1 Plasmid Construction and Delivery for the Treatment of Type 2 Diabetes
Choi, S., Oh, S., Lee, M., & Kim, S. W. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.039 · Cited by 33
Zamaratskaia, G., Johansson, D. P., Junqueira, M. A., Deissler, L., Langton, M., Hellström, P. M., & Landberg, R. (2017) · British Journal Of Nutrition · doi:10.1017/s000711451700263x · Cited by 37
Glucagon‐like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle
Abdulla, H., Phillips, B. E., Wilkinson, D. J., Limb, M., Jandova, T., Bass, J. J., Rankin, D., Cegielski, J., Sayda, M., Crossland, H., et al. (2020) · Aging Cell · doi:10.1111/acel.13202 · Cited by 30
Süyen, G. G., Işbil-Büyükcoşkun, N., & Kahveci, N. (2010) · Neuropeptides · doi:10.1016/j.npep.2010.02.002 · Cited by 34
Chyan, Y., & Chuang, L. (2007) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/187221407779814570 · Cited by 37
Tatarkiewicz, K., Hargrove, D. M., Jodka, C. M., Gedulin, B. R., Smith, P. A., Hoyt, J. A., Lwin, A., Collins, L., Mamedova, L., Levy, O. E., et al. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12181 · Cited by 32
Glucagon‐like peptide‐1: The missing link in the metabolic clock?
Brubaker, P. L., & Gil‐Lozano, M. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12477 · Cited by 39
Dorsal striatum dopamine oscillations: Setting the pace of food anticipatory activity
de Lartigue, G., & McDougle, M. J. (2018) · Acta Physiologica · doi:10.1111/apha.13152 · Cited by 34
Alliances of the gut and bone axis
Hansen, M. S., & Frost, M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.06.024 · Cited by 34
The Effect of Extruded Orange Pulp on Enzymatic Hydrolysis of Starch and Glucose Retardation Index
Céspedes, M. Á. L., Bustos, F. M., & Chang, Y. K. (2009) · Food and Bioprocess Technology · doi:10.1007/s11947-008-0166-7 · Cited by 32
Metabolism of GIP and the contribution of GIP to the glucose-lowering properties of DPP-4 inhibitors
Deacon, C. F. (2020) · Peptides · doi:10.1016/j.peptides.2019.170196 · Cited by 31
Renner, S., Blutke, A., Streckel, E., Wanke, R., & Wolf, E. (2015) · The Journal of Pathology · doi:10.1002/path.4655 · Cited by 35
Fukumori, R., Mita, T., Sugino, T., Obitsu, T., & Taniguchi, K. (2012) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2012.05.003 · Cited by 31
Janssens, J., Etienne, H., Idriss, S., Azmi, A., Martin, B., & Maudsley, S. R. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00142 · Cited by 32
Puddu, A., Mach, F., Nencioni, A., Viviani, G. L., & Montecucco, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/591056 · Cited by 35
Sakuma, M., Yamanaka‐Okumura, H., Naniwa-Kuroki, Y., Matsumoto, D., Tsunematsu, M., Yamamoto, H., Taketani, Y., & Takeda, E. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.08-232 · Cited by 32
Lampropoulos, C., Alexandrides, T., Tsochatzis, S., Kehagias, D., & Kehagias, I. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05568-7 · Cited by 30
Fernández‐García, J. C., Murri, M., Coín‐Aragüez, L., Alcaide, J., Bekay, R. E., & Tinahones, F. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12221 · Cited by 34
Guccio, N., Gribble, F. M., & Reimann, F. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062320-113625 · Cited by 35
Alsalim, W., Lindgren, O., & Åhrén, B. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13962 · Cited by 30
Nishimura, K., Hiramatsu, K., Monir, M. M., Takemoto, C., & Watanabe, T. (2013) · Journal of Veterinary Medical Science · doi:10.1292/jvms.13-0106 · Cited by 34
Chang, E., Kim, L., Choi, J. M., Park, S. E., Rhee, E., Lee, W., Oh, K.-W., Park, S., Park, D. I., & Park, C. (2015) · Metabolism · doi:10.1016/j.metabol.2015.02.001 · Cited by 30
Shimotoyodome, A., Suzuki, J., Kameo, Y., & Hase, T. (2011) · British Journal of Nutrition · doi:10.1017/s0007114510005854 · Cited by 29
Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117
Qian, F., Mathias, N. R., Moench, P. A., Chi, C. L., Desikan, S., Hussain, M. A., & Smith, R. L. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.020 · Cited by 32
Uehara, S., Jung, S.-K., Morimoto, R., Arioka, S., Miyaji, T., Juge, N., Hiasa, M., Shimizu, K., Ishimura, A., Otsuka, M., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03575.x · Cited by 35
Galanin is a potent inhibitor of glucagon-like peptide-1 secretion from rat ileum
Herrmann-Rinke, C., Hörsch, D., McGregor, G. P., & Göke, B. (1996) · Peptides · doi:10.1016/0196-9781(96)00072-1 · Cited by 37
L-arginine increases postprandial circulating GLP-1 and PYY levels in humans
Amin, A., Neophytou, C., Thein, S., Martin, N. M., Alamshah, A., Spreckley, E., Bloom, S. R., & Murphy, K. G. (2018) · Obesity · doi:10.1002/oby.22323 · Cited by 29
“Peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) are released from endocrine cells in the gut in response to food intake and reduce food intake following peripheral administration in animals and humans (13,14).”
BackgroundInfluentialMa, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.03.009 · Cited by 35
Gut peptides in the treatment of diabetes mellitus
Vahl, T. P., & D’Alessio, D. A. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.3.177 · Cited by 31
The Entero-Insular Axis in Polycystic Ovarian Syndrome
Garaa, R., Norris, F., Wright, J., Morgan, L., Hampton, S., Watkins, K., & Marks, V (1996) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329603300303 · Cited by 27
Self-citationThe effect of circulating non‐esterified fatty acids on the entero‐insular axis
Ranganath, Norris, Morgan, Wright, & Marks (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00426.x · Cited by 29
Exendin-4, a GLP-1 Receptor Agonist, Modulates the Effect of Macronutrients on Food Intake by Rats
Aziz, A. A., & Anderson, G. H. (2002) · Journal of Nutrition · doi:10.1093/jn/132.5.990 · Cited by 32
Hunt, J. E., Hartmann, B., Schoonjans, K., Holst, J. J., & Kissow, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.640602 · Cited by 29
Mechanisms for the cardiovascular effects of glucagon-like peptide-1
Poudyal, H. (2015) · Acta Physiologica · doi:10.1111/apha.12604 · Cited by 34
Lobley, G. E., Holtrop, G., Horgan, G. W., Bremner, D. M., Fyfe, C., & Johnstone, A. M. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515000069 · Cited by 27
Inabu, Y., Saegusa, A., Inouchi, K., Koike, S., Oba, M., & Sugino, T. (2017) · Journal of Dairy Science · doi:10.3168/jds.2017-12910 · Cited by 27
O’Malley, D. (2018) · Experimental Physiology · doi:10.1113/ep087443 · Cited by 30
Doğruel, H., & Balcı, M. K. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i8.446 · Cited by 28
The early history of GIP 1969–2000: From enterogastrone to major metabolic hormone
Marks, V. (2020) · Peptides · doi:10.1016/j.peptides.2020.170276 · Cited by 27
Self-citationJackson, K. G., Zampelas, A., Knapper, J. M. E., Roche, H. M., Gibney, M. J., Kafatos, A., GOULD, B. J., Wright, J. W., & Williams, C. M. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.13 · Cited by 28
Self-citationThe influence of the colon on postprandial glucagon-like peptide 1 (7-36) amide concentration in man
Robertson, M. D., Livesey, G., Morgan, L., Hampton, S., & Mathers, J. C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610025 · Cited by 28
Self-citationWikarek, T., Chudek, J. T., Owczarek, A. J., & Olszanecka‐Glinianowicz, M. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513002389 · Cited by 28
Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
Zilstorff, D. B., Richter, M. M., Hannibal, J., Jørgensen, H. L., Sennels, H. P., & Albrechtsen, N. J. W. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01566-9 · Cited by 26
Contributions of fat and protein to the incretin effect of a mixed meal
Carrel, G., Egli, L., Tran, C., Schneiter, P., Giusti, V., D’Alessio, D. A., & Tappy, L. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.017574 · Cited by 28
The role of food intake regulating peptides in cardiovascular regulation
Mikulášková, B., Maletínská, L., Zicha, J., & Kuneš, J. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.021 · Cited by 27
Molecular regulation of insulin granule biogenesis and exocytosis
Röder, P. V., Wong, X. M., Hong, W., & Han, W. (2016) · Biochemical Journal · doi:10.1042/bcj20160291 · Cited by 33
Bendet, N., Scapa, E. F., Cohen, O., Bloch, O., Aharoni, D., Ramot, Y., Weiss, M., Halevi, A., & Rapoport, M. J. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410004839 · Cited by 27
Incretin-based therapeutics for the treatment of neurodegenerative diseases
Vear, A., Heneka, M. T., & Clemmensen, C. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01263-4 · Cited by 26
Chen, Y., Li, Z., Yang, Y., Lin, L., & Zhang, H. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1252 · Cited by 25
Okimura, T., Jiang, Z., Liang, Y., Yamaguchi, K., & Oda, T. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.12.084 · Cited by 26
Chronodisruption by chronic jetlag impacts metabolic and gastrointestinal homeostasis in male mice
Desmet, L., Thijs, T., Segers, A., Verbeke, K., & Depoortere, I. (2021) · Acta Physiologica · doi:10.1111/apha.13703 · Cited by 28
de Menthière, C. S., Chavanieu, A., Grassy, G., Dalle, S., Salazar, G., Kervran, A., Pfeiffer, B., Renard, P., Delagrange, P., Manéchez, D., et al. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.02.002 · Cited by 24
Puddu, A., Sanguineti, R., Montecucco, F., & Viviani, G. L. (2014) · Mediators of Inflammation · doi:10.1155/2014/923120 · Cited by 24
Hansen, C. F., Vassiliadis, E., Vrang, N., Sangild, P. T., Cummings, B. P., Havel, P. J., & Jelsing, J. (2014) · Regulatory Peptides · doi:10.1016/j.regpep.2014.01.002 · Cited by 26
Meissner, M., Herrema, H., van Dijk, T. H., Gerding, A., Havinga, R., Boer, T. S., Müller, M. M., Reijngoud, D., Groen, A. K., & Kuipers, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024564 · Cited by 25
Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy males
Wu, T., Rayner, C. K., Watson, L. E., Jones, K. L., Horowitz, M., & Little, T. J. (2017) · Peptides · doi:10.1016/j.peptides.2017.08.001 · Cited by 23
Lencioni, C., Resi, V., Romero, F., Lupi, R., Volpe, L., Bertolotto, A., Ghio, A., Prato, S. D., Marchetti, P., & Cianni, G. D. (2011) · PubMed · doi:10.3275/7799 · Cited by 23
Miholic, J., Hoffmann, M., Holst, J. J., Lenglinger, J., Mittlböck, M., Bergmann, H., & Stacher, G. (2007) · Surgical Endoscopy · doi:10.1007/s00464-005-0804-3 · Cited by 23
Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver disease
Pols, T. W. H., Auwerx, J. H., & Schoonjans, K. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2010.03.009 · Cited by 23
Delmeire, D., Flamez, D., Moens, K., Hinke, S. A., Schravendijk, C. V., PIPELEERS, D. G., & Schuit, F. C. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.02.035 · Cited by 24
Millar, P., Pathak, V., Moffett, R. C., Pathak, N., Bjourson, A. J., O’Kane, M., Flatt, P. R., & Gault, V. A. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.019 · Cited by 24
Meal-Sensing Signaling Pathways in Functional Dyspepsia
Page, A. J., & Li, H. (2018) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2018.00010 · Cited by 23
Incretin-Based Therapy and Type 2 Diabetes
Hare, K. J., & Knop, F. K. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00015-1 · Cited by 24
Pridal, L., Ingwersen, S. H., Larsen, F. S., Holst, J. J., Adelhorst, K., & Kirk, O. (1995) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(95)01312-9 · Cited by 23
Metadata
- Authors
- Elliott, R. M., Morgan, L. M., Tredger, J. A., Deacon, S., Wright, J., & Marks, V.
- Affiliations
- University of Surrey (GB)
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 1993-07-01
- Volume
- 138
- Issue
- 1
- Pages
- 159-166
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2027593203
- Cited by
- 695
- References
- 0
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 15 · 2023: 11 · 2022: 20 · 2021: 28 · 2020: 16 · 2019: 26 · 2018: 28 · 2017: 23 · 2016: 19 · 2015: 36 · 2014: 35 · 2013: 39 · 2012: 32
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Funders
- Ministry of Agriculture, Forestry and Fisheries
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- glucagon-like peptide-1(7-36)amide, glucose-dependent insulinotropic polypeptide, incretins, postprandial hormone secretion, carbohydrate intake, dietary fat, dietary protein, glucose, barley, brown rice, insulin, lipid metabolism
- MeSH terms
- Adult, Blood Glucose, Circadian Rhythm, Dietary Carbohydrates, Dietary Fats, Dietary Proteins, Eating, Glucagon-Like Peptides, Gastric Inhibitory Polypeptide, Glucagon, Glucose, Humans, Insulin, Nutritional Physiological Phenomena, Peptide Fragments, Radioimmunoassay, Time Factors, Lipid Metabolism, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.